The pace of innovation in oncology is accelerating — but turning breakthroughs into real-world patient impact requires significant commercial investment, often starting years before approval. To help busy clinicians keep pace with this rapid evolution and ensure patients quickly get the therapies they need, commercial teams must be equipped with the most accurate, insightful data available. | The pace of innovation in oncology is accelerating — but turning breakthroughs into real-world patient impact requires significant commercial investment, often starting years before approval. To help busy clinicians keep pace with this rapid evolution and ensure patients quickly get the therapies they need, commercial teams must be equipped with the most accurate, insightful data available.